Back to News
Market Impact: 0.12
PerZeption Awarded NEI Phase 1 SBIR Grant for Age-related Macular Degeneration Study
Source: PR Newswire
Healthcare & BiotechTechnology & Innovation
PerZeption Inc. received a Phase I Small Business Innovation Research (SBIR) grant from the National Eye Institute for a project focused on efficient achromatic and chromatic photostress recovery assessment for age-related macular degeneration. The announcement supports early-stage development of the company's ophthalmic assessment technology, though no grant amount or commercialization timeline was disclosed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
More News
- Jio shares surge 21% in market debut after blockbuster India IPO
- Oracle integrates ChatGPT, Codex into apps and expands cloud chip lineup
- Asian tech stocks rally as SK Hynix vows $75B in shareholder returns after Q3 beat
- Meta- and Google-backed Jio Platforms’ shares soar over 21% on trading debut after record IPO
- Jio shares surge over 20% in blockbuster market debut
- Dassault Systèmes raises 2026 outlook as revenue growth rebound gathers pace